These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36737665)

  • 1. The role of the farnesoid X receptor in kidney health and disease: a potential therapeutic target in kidney diseases.
    Kim DH; Park JS; Choi HI; Kim CS; Bae EH; Ma SK; Kim SW
    Exp Mol Med; 2023 Feb; 55(2):304-312. PubMed ID: 36737665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acid receptors and the kidney.
    Herman-Edelstein M; Weinstein T; Levi M
    Curr Opin Nephrol Hypertens; 2018 Jan; 27(1):56-62. PubMed ID: 29045336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism.
    Zhou W; Anakk S
    Mol Cell Endocrinol; 2022 Jun; 549():111616. PubMed ID: 35304191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of FXR in Renal Physiology and Kidney Diseases.
    Guo Y; Xie G; Zhang X
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
    J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
    Jiang T; Wang XX; Scherzer P; Wilson P; Tallman J; Takahashi H; Li J; Iwahashi M; Sutherland E; Arend L; Levi M
    Diabetes; 2007 Oct; 56(10):2485-93. PubMed ID: 17660268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of carbohydrate metabolism by the farnesoid X receptor.
    Stayrook KR; Bramlett KS; Savkur RS; Ficorilli J; Cook T; Christe ME; Michael LF; Burris TP
    Endocrinology; 2005 Mar; 146(3):984-91. PubMed ID: 15564327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model.
    Wang XX; Jiang T; Shen Y; Caldas Y; Miyazaki-Anzai S; Santamaria H; Urbanek C; Solis N; Scherzer P; Lewis L; Gonzalez FJ; Adorini L; Pruzanski M; Kopp JB; Verlander JW; Levi M
    Diabetes; 2010 Nov; 59(11):2916-27. PubMed ID: 20699418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
    Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
    Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
    Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
    Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model.
    Han SY; Song HK; Cha JJ; Han JY; Kang YS; Cha DR
    Acta Diabetol; 2021 Apr; 58(4):495-503. PubMed ID: 33399988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel role for farnesoid X receptor in the bile acid-mediated intestinal glucose homeostasis.
    Zhao L; Xuan Z; Song W; Zhang S; Li Z; Song G; Zhu X; Xie H; Zheng S; Song P
    J Cell Mol Med; 2020 Nov; 24(21):12848-12861. PubMed ID: 33029898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice.
    Gai Z; Gui T; Hiller C; Kullak-Ublick GA
    J Biol Chem; 2016 Jan; 291(5):2397-411. PubMed ID: 26655953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Farnesoid X receptor (FXR): a novel regulative factor involved in metabolism].
    Zhang XY; Guan YF
    Sheng Li Ke Xue Jin Zhan; 2007 Jul; 38(3):219-23. PubMed ID: 17882978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice.
    Massafra V; Milona A; Vos HR; Ramos RJJ; Gerrits J; Willemsen ECL; Ramos Pittol JM; Ijssennagger N; Houweling M; Prinsen HCMT; Verhoeven-Duif NM; Burgering BMT; van Mil SWC
    Gastroenterology; 2017 May; 152(6):1462-1476.e10. PubMed ID: 28130067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesoid X receptor: A "homeostat" for hepatic nutrient metabolism.
    Massafra V; van Mil SWC
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):45-59. PubMed ID: 28986309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile salts in control of lipid metabolism.
    Schonewille M; de Boer JF; Groen AK
    Curr Opin Lipidol; 2016 Jun; 27(3):295-301. PubMed ID: 27031274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesoid X receptor: a potential therapeutic target in multiple organs.
    Zhang C; Wang Z; Feng Q; Chen WD; Wang YD
    Histol Histopathol; 2020 Dec; 35(12):1403-1414. PubMed ID: 33393073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid nuclear receptor FXR and digestive system diseases.
    Ding L; Yang L; Wang Z; Huang W
    Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
    Claudel T; Staels B; Kuipers F
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2020-30. PubMed ID: 16037564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.